A hybrid derived from the fusion of a myeloma cell (HPRT−) with an antibody secreting B-lymphocyte (HPRT+) can be selected to produce monoclonal antibody by growing in a medium containing
A. Thiamine, Hypoxanthine, Aminopterin
B. Thymidine, Histidine, Aminopterin
C. Uridine, Hypoxanthine, Aminopterin
D. Thymidine, Hypoxanthine, Aminopterin
Answer: Option D
Join The Discussion